Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dismantling the pyramid.

J E Levinson1, C A Wallace

  • 1Department of Pediatrics, University of Cincinnati, Children's Hospital Medical Center, OH 45229-2899.

The Journal of Rheumatology. Supplement
|April 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Environmental Risk Factors and Early-Life Exposures in Juvenile Idiopathic Arthritis: A Case-Control Study.

Arthritis care & research·2015
Same author

Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis.

Arthritis and rheumatism·2009
Same author

Stress-Related Changes in beta-Endorphin Processing: The Limitations of Slaughterhouse Material.

Journal of neuroendocrinology·2009
Same author

The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathy.

Rheumatology (Oxford, England)·2007
Same author

What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?

Clinical and experimental rheumatology·2006
Same author

Macrophage activation syndrome and other systemic inflammatory conditions after BMT.

Bone marrow transplantation·2006
Same journal

GRAPPA 2019 Research Recipient Awards Report.

The Journal of rheumatology. Supplement·2021
Same journal

GRAPPA Treatment Recommendations: An Update From the 2020 GRAPPA Annual Meeting.

The Journal of rheumatology. Supplement·2021
Same journal

GRAPPA Patient Research Partner Network: Update to the GRAPPA 2020 Annual Meeting.

The Journal of rheumatology. Supplement·2021
Same journal

Instruments Measuring Physical Function for Psoriatic Arthritis Endorsed at GRAPPA 2020 Annual Meeting: Updates of the GRAPPA-OMERACT Working Group.

The Journal of rheumatology. Supplement·2021
Same journal

GRAPPA 2020 Update From the Education Committee.

The Journal of rheumatology. Supplement·2021
Same journal

The Role of Ultrasound in Research and Clinical Practice in Psoriatic Arthritis: Highlights From the GRAPPA Ultrasound Workshop.

The Journal of rheumatology. Supplement·2021
See all related articles

Early and decisive treatment for juvenile rheumatoid arthritis (JRA) is proposed to induce remission, preserve function, and improve quality of life. This approach challenges traditional therapeutic pyramids for JRA management.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Clinical Medicine

Background:

  • Traditional treatment paradigms for juvenile rheumatoid arthritis (JRA) are being questioned.
  • There is a growing call to reorder medical management for JRA.

Purpose of the Study:

  • To critically evaluate current treatment strategies for JRA.
  • To propose a reassessment of JRA management approaches for the 1990s.
  • To advocate for early and decisive intervention to achieve disease remission.

Main Methods:

  • Scrutiny of existing treatment paradigms.
  • Review of current clinical practices in JRA management.
  • Updating and analyzing data from established JRA treatment protocols.

Related Experiment Videos

Main Results:

  • Analysis indicates a need to re-evaluate the established 'therapeutic pyramid' for JRA.
  • Current data supports the benefits of early and aggressive treatment strategies.
  • Prompt remission is achievable and crucial for long-term outcomes.

Conclusions:

  • Dismantling the traditional therapeutic pyramid for JRA is suggested.
  • Reordering medical management to prioritize early, decisive treatment is recommended.
  • Achieving prompt remission is key to preserving joint function and quality of life in JRA patients.